In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-22 of 22 for your search:
Drug:  palifermin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703

2.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040122, NCT00393822

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0012064, AMGEN-KGF-20000162, FHCRC-1612.00, MSKCC-01065, NCI-G01-1961

4.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20020402, NCT00101582

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040118, NCT00131638

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050219, NCT00434161

7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Unknown
Age: 25 to 65
Sponsor: Other
Protocol IDs: UCL-08-0167, UCL/08/0167, EU-21009, EUDRACT-2009-012717-22, UCL-UKALL14, MREC-09-H0711-90, NCRI-UCL-08-0167, CRUK-C27995-A9609, NCT01085617

8.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97112, AMGEN-KGF-960189, NCI-G97-1368

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Adult
Sponsor: NCI
Protocol IDs: RPCI-DS-97-33, AMGEN-KGF-970149-08, NCI-G98-1397

10.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-99029, AMGEN-KGF-980231-04, NCI-G99-1574, NCT00004061

11.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 65
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-9812041, AMGEN-KGF-980231-03, NCI-G99-1609, NCT00004132

12.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20030185, NCT00094861

13.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040213, NCT00189488

14.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2004-0511, NCT00267046

15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Under 65
Sponsor: Other
Protocol IDs: 08-008, NCT00629798

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2010-0506, NCI-2012-01906, NCT01237951

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 12-388, NCT01746173

18.

Phase: Phase I
Type: Supportive care
Status: Completed
Age: 18 to 76
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010182, NCT00070616

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 16
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010133, NCT00460421

20.

Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000547155, P30CA022453, WSU-2006-119, NCT00482846

21.

Phase: Phase I
Type: Supportive care
Status: Completed
Age: 2 to 18
Sponsor: Other
Protocol IDs: PALSCT, NCT00701688

22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 2437.00, NCI-2010-01711, NCT01233921
New Search